# EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
> **NDA204568** · New Drug Application · Sponsor: CIPLA · Approved 2013-12-30
## Drug
- **FDA Application Number:** NDA204568
- **Application type:** New Drug Application
- **Brand name:** EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Efavirenz
- **Active ingredients:** EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA
- **First approval:** 2013-12-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204568)
---
*MORVS · CC0 1.0*